CDKN2B and fatty liver disease: The genes neighboring ANRIL have also been reported to have a role in metabolic regulation, as CDKN2B is highly expressed in subcutaneous adipose tissue (SAT), with the levels positively correlating with obesity and hepatic steatosis in 9p21.3 risk allele carriers [22].